Sign in
4

Changes in Ownership

Hepion Pharmaceuticals, Inc. Filed Acc 0001104659-17-044100

Chief Executive Officer acquired 141,061 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

SAPIRSTEIN JAMES · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2017-07-06 Grant or award : show line 1 in the form +141,061 170,727 D
Loading xslF345X03/a4.xml…